The chemical company has told creditors it may skip the upcoming payments, and is discussing options to address its more than more than $1 billion of debt, said the people, who declined to be named discussing private information. The company’s earnings have plummeted as it deals with the fallout of a string of crises.
The Houston-based company faced a plant
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.